Cargando…

Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial

Introduction To compare myopia progression in school-aged children of Caucasian origin wearing part-time vs. full-time full correction with single-vision spectacles. Methods This prospective, randomized controlled trial included 30 children with bilateral myopia, who received either full-time or par...

Descripción completa

Detalles Bibliográficos
Autores principales: Prousali, Efthymia, Haidich, Anna-Bettina, Dastiridou, Anna, Tzamalis, Argyrios, Ziakas, Nikolaos, Mataftsi, Asimina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202340/
https://www.ncbi.nlm.nih.gov/pubmed/35720776
http://dx.doi.org/10.7759/cureus.25995
_version_ 1784728513579843584
author Prousali, Efthymia
Haidich, Anna-Bettina
Dastiridou, Anna
Tzamalis, Argyrios
Ziakas, Nikolaos
Mataftsi, Asimina
author_facet Prousali, Efthymia
Haidich, Anna-Bettina
Dastiridou, Anna
Tzamalis, Argyrios
Ziakas, Nikolaos
Mataftsi, Asimina
author_sort Prousali, Efthymia
collection PubMed
description Introduction To compare myopia progression in school-aged children of Caucasian origin wearing part-time vs. full-time full correction with single-vision spectacles. Methods This prospective, randomized controlled trial included 30 children with bilateral myopia, who received either full-time or part-time treatment with single-vision spectacle lenses. Myopia progression was assessed as the mean change in cycloplegic spherical equivalent refraction (SE), mean change in axial length (AL), and mean change in sub-foveal choroidal thickness (SChT), over a 12-month follow-up period. Results A total of 32 eyes were treated with part-time single-vision spectacles (intervention group) and 28 eyes with full-time single-vision spectacles (control group), respectively. The part-time treated group reported no spectacle use during near-work activities for a mean of 6.2 hours/day. At the 12-month assessment, there was no significant difference between part-time and full-time correction groups in mean SE change (MD: -0.05 D, 95% CI: -0.50 - 0.39 D; P 0.81), in mean AL change (MD: -0.07 mm; 95% CI: -0.20 - 0.06 mm; P 0.30), and in mean SChT change (MD: -11.45 μm; 95% CI -22.60 - 14.16 μm; P 0.67). Conclusion Myopia progression in Caucasian children treated with part-time, single-vision spectacle use was not different compared to full-time, single-vision spectacle use, over a 12-month follow-up period.
format Online
Article
Text
id pubmed-9202340
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92023402022-06-17 Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial Prousali, Efthymia Haidich, Anna-Bettina Dastiridou, Anna Tzamalis, Argyrios Ziakas, Nikolaos Mataftsi, Asimina Cureus Ophthalmology Introduction To compare myopia progression in school-aged children of Caucasian origin wearing part-time vs. full-time full correction with single-vision spectacles. Methods This prospective, randomized controlled trial included 30 children with bilateral myopia, who received either full-time or part-time treatment with single-vision spectacle lenses. Myopia progression was assessed as the mean change in cycloplegic spherical equivalent refraction (SE), mean change in axial length (AL), and mean change in sub-foveal choroidal thickness (SChT), over a 12-month follow-up period. Results A total of 32 eyes were treated with part-time single-vision spectacles (intervention group) and 28 eyes with full-time single-vision spectacles (control group), respectively. The part-time treated group reported no spectacle use during near-work activities for a mean of 6.2 hours/day. At the 12-month assessment, there was no significant difference between part-time and full-time correction groups in mean SE change (MD: -0.05 D, 95% CI: -0.50 - 0.39 D; P 0.81), in mean AL change (MD: -0.07 mm; 95% CI: -0.20 - 0.06 mm; P 0.30), and in mean SChT change (MD: -11.45 μm; 95% CI -22.60 - 14.16 μm; P 0.67). Conclusion Myopia progression in Caucasian children treated with part-time, single-vision spectacle use was not different compared to full-time, single-vision spectacle use, over a 12-month follow-up period. Cureus 2022-06-16 /pmc/articles/PMC9202340/ /pubmed/35720776 http://dx.doi.org/10.7759/cureus.25995 Text en Copyright © 2022, Prousali et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Prousali, Efthymia
Haidich, Anna-Bettina
Dastiridou, Anna
Tzamalis, Argyrios
Ziakas, Nikolaos
Mataftsi, Asimina
Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title_full Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title_fullStr Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title_full_unstemmed Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title_short Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study): A Randomized Clinical Trial
title_sort part-time versus full-time spectacles for myopia control (parma study): a randomized clinical trial
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202340/
https://www.ncbi.nlm.nih.gov/pubmed/35720776
http://dx.doi.org/10.7759/cureus.25995
work_keys_str_mv AT prousaliefthymia parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial
AT haidichannabettina parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial
AT dastiridouanna parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial
AT tzamalisargyrios parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial
AT ziakasnikolaos parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial
AT mataftsiasimina parttimeversusfulltimespectaclesformyopiacontrolparmastudyarandomizedclinicaltrial